iThera Medical reports initiation of fifth clinical site in ongoing study for the non-invasive assessment of inflammatory bowel disease
Munich, DE – Medical device company iThera Medical announces that the fifth site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). […]
iThera Medical leads €1.6m project to develop novel machine learning-assisted optoacoustic imaging of neuromuscular disease
Medical device company iThera Medical announces the kickoff of the technology innovation project SMART-3D funded by the Bavarian Research Foundation. Commenced on 01 May 2022, the project aims to develop an innovative new approach to monitor neuromuscular disease in pediatric patients through the company’s proprietary optoacoustic imaging technology and next-generation 3D image reconstruction assisted by […]
iThera Medical awarded major European grant to translate its optoacoustic imaging technology from research to routine clinical use
Munich, DE – Medical device company iThera Medical announces successful funding of the Horizon Europe technology innovation project FRONTIER. Under the EIC Accelerator program, Europe’s largest and most selective public funding program for breakthrough innovation projects, the EU will provide €2.5 million grant funding and up to €15 million equity. Through this project, iThera Medical […]
iThera Medical introduces the world’s first transmission ultrasound system
Imaging device company iThera Medical announces the launch of its new inVision TRIO preclinical optoacoustic imaging system. The inVision TRIO is the first imaging system in the world that incorporates transmission ultrasound computed tomography (TUCT) and expands the field of biomedical applications addressable using iThera Medical’s optoacoustic imaging systems. As the world leader in optoacoustic […]
iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease
Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The chronic condition […]
iThera Medical leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis
Medical device company iThera Medical announces the kickoff of the Bavarian state-funded technology innovation project DeepOPUS. The project aims to augment the company’s proprietary optoacoustic imaging technology using AI technology, developing it into a quantitative diagnostic method for inflammatory bowel disease (IBD) and beyond. Multispectral optoacoustic tomography (MSOT) is an innovative, non-invasive diagnostic imaging method […]
CE Mark awarded to iThera Medical’s second-generation MSOT Acuity Echo optoacoustic imaging system
The Munich-based biomedical imaging company was awarded the CE Mark for its MSOT Acuity Echo imaging system, indicating conformity with health, safety and environmental protection for medical devices sold in Europe. Following the first CE mark for its optoacoustic imaging system MSOT Acuity in 2019, this newly CE-marked device now combines optoacoustic with ultrasound tomography. […]
We have received approval for a pivotal clinical trial to assess colon inflammation in patients with inflammatory bowel disease using optoacoustic imaging
Patients with the chronic condition IBD undergo recurring phases of inflammation and remission of the gastrointestinal tract. In treatment management of IBD, it is necessary to closely monitor inflammatory activity of the bowel wall. Persistent inflammatory activity is related to higher complication rates, hospitalization, and cancer – all of which may be avoided by early […]
RSOM demonstrates high-resolution imaging of tumor microvasculature and targeted therapy response
In a study published in Nature Biomedical Engineering, raster-scanning optoacoustic mesoscopy (RSOM) provided an unprecedented means of studying tumor vasculature during therapy. Commercialized by the Munich-based company iThera Medical, this technology enabled non-invasive investigation of in vivo tumor response in high resolution. In the ongoing search for new and better means of combating cancer, localized […]
Translational study demonstrates value of MSOT imaging for the assessment of disease progression in Duchenne muscular dystrophy
A translational study conducted at the University Hospital Erlangen and published in Nature Medicine demonstrates that Multispectral Optoacoustic Tomography (MSOT) can be used to visualize and quantify changes in tissue composition associated with the progression of the rare muscle disease Duchenne Muscular Dystrophy (DMD). While the established clinical outcome measures largely rely on physiological and […]